Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/27/2008WO2008142433A1 Process for producing compositions comprising tocoherols and tocotrienols
11/27/2008WO2008142397A1 Serine protease inhibitors for use in the treatment of bacterial infections
11/27/2008WO2008142384A1 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008142285A1 Nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
11/27/2008WO2008142267A2 Process for extracting coumarins
11/27/2008WO2008142231A2 Novel composition based on cholest-4-ene-3-one oxime
11/27/2008WO2008142178A1 Method for obtaining extracts with high-content in hydroxytyrosol from olive sub-products
11/27/2008WO2008142147A1 Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis
11/27/2008WO2008142140A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/27/2008WO2008142134A1 Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions
11/27/2008WO2008142106A1 Salts of picotamide
11/27/2008WO2008142094A1 Triazol compounds for treating biofilm formation
11/27/2008WO2008142090A1 Self-emulsifying formulation of tipranavir for oral administration
11/27/2008WO2008142073A1 Benzamides useful as s1p receptor modulators
11/27/2008WO2008142046A1 Etnangien derivatives and their use as antibiotics
11/27/2008WO2008142031A1 P38alpha as a therapeutic target in bladder carcinoma
11/27/2008WO2008141976A1 Diacylglycerol acyltransferase inhibitors
11/27/2008WO2008141975A1 Spiroindolinone derivatives
11/27/2008WO2008141917A1 3,3-spiroindolinone derivatives
11/27/2008WO2008141897A1 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
11/27/2008WO2008141888A1 Oral dosage form providing fast absorption of drug
11/27/2008WO2008141843A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
11/27/2008WO2008141796A1 Treatment of ddr1 positive cancer using imatinib
11/27/2008WO2008141764A1 Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems
11/27/2008WO2008141751A2 Pharmaceutical compositions comprising oxcarbazepine
11/27/2008WO2008141731A2 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11/27/2008WO2008141570A1 A composition for improving quality of fetus, preventing and treating birth defects
11/27/2008WO2008141462A1 Novel case of renin inhibitors
11/27/2008WO2008141455A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/27/2008WO2008141446A1 Amino acid derivatives as calcium channel blockers
11/27/2008WO2008141438A1 Gabaergic modulators for treating airway conditions
11/27/2008WO2008141385A1 Viral polymerase inhibitors
11/27/2008WO2008141368A1 Combination laxative compositions comprising a colonic stimulant and a bulking laxative
11/27/2008WO2008141353A1 Prevention of acute kidney injury
11/27/2008WO2008124660A3 Methods and compositions for the treatment of cancer
11/27/2008WO2008122032A3 Treatment method for mmp-implicated pathologies
11/27/2008WO2008121850A3 Small-molecule modulators of melanin expression
11/27/2008WO2008121742A3 Inhibitors of bruton's tyrosine kinase
11/27/2008WO2008121102A3 Hedgehog signaling pathway antagonist cancer treatment
11/27/2008WO2008118457A3 Synthesis of resolvins and intermediates, compounds prepared thereby, and uses thereof
11/27/2008WO2008118122A3 Compounds and amyloid probes thereof for therapeutic and imaging uses
11/27/2008WO2008116825A3 Compositions and method for treating pediatric hypogonadism
11/27/2008WO2008116813A9 Combination medicaments for treating bacterial infections
11/27/2008WO2008116156A3 Methods and compositions for treating diseases and conditions associated with mitochondrial function
11/27/2008WO2008112651A3 Aminopyrimidines useful as inhibitors of protein kinases
11/27/2008WO2008112525A3 Treatment of lysosomal storage diseases
11/27/2008WO2008109731A3 Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators
11/27/2008WO2008109532A3 Nucleic acid compounds for inhibiting fas gene expression and uses thereof
11/27/2008WO2008109461B1 Nucleic acid compounds for inhibiting cd3 gene expression and uses thereof
11/27/2008WO2008109373B1 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
11/27/2008WO2008109083A3 Restrictive agonist of toll-like receptor 3 (tlr3)
11/27/2008WO2008107781A3 Triazolquinolonic derivatives with antimycobacterial activity
11/27/2008WO2008106619A3 Indenoisoquinolinone analogs and methods of use thereof
11/27/2008WO2008106571A3 Sustained release parenteral formulations of buprenorphine
11/27/2008WO2008103753A3 Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
11/27/2008WO2008103483A3 Marine alkaloid makaluvamines and derivatives thereof
11/27/2008WO2008101723A3 Pharmaceutical composition containing a cholesterol absorption inhibitor
11/27/2008WO2008101693A3 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
11/27/2008WO2008101692A3 Cosmetic and pharmaceutical applications of n-acetylhydroxyproline
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/27/2008WO2008101233A3 Mitochondrial nucleic acid delivery systems
11/27/2008WO2008097971A3 Methods for treating diseases of altered ige regulation
11/27/2008WO2008096804A8 Eye drop preparation comprising latanoprost
11/27/2008WO2008096271A3 Neuroprotection in demyelinating diseases
11/27/2008WO2008092072A3 Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof
11/27/2008WO2008091525A3 Anthelmintic macrolactams from nonmuraea turkmeniaca ma 7364
11/27/2008WO2008090471A3 Use of compositions comprising at least one alfa3 beta4 nachr antagonist such as mecamylamine in the treatment of gastrointestinal disorders
11/27/2008WO2008089125A3 Antiviral compounds and methods of using thereof
11/27/2008WO2008087489A8 Treating cancer using electromagnetic fields in combination with other treatment regimens
11/27/2008WO2008087365A3 Substituted 1, 3-diphenylpropane derivatives, preparations and uses of same
11/27/2008WO2008087123A3 Use of 5-ht6 antagonists to prevent relapse into addiction
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008083192A3 Methods and formulations for improved bioavailability of antiprogestins
11/27/2008WO2008083038A8 Methods and compositions for repelling arthropods
11/27/2008WO2008080060A3 4-se-thymidine derivatives, 4-se-uridine derivatives, di (2-cyanoethyl) diselenide, and methods
11/27/2008WO2008080037A3 Carotenoids of enhanced bioavailability
11/27/2008WO2008076806A3 Compositions and methods to potentiate colistin activity
11/27/2008WO2008076554A3 Methods for modifying virus surfaces
11/27/2008WO2008073670A3 Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
11/27/2008WO2008071573A3 Powder formulation for valganciclovir
11/27/2008WO2008071438A3 Treatment of disease or injury of the nervous system using agents that decrease the activity of the melanocortin 4 receptor
11/27/2008WO2008070875A3 Polyhydroquinoline compounds and dihydropyridine compounds for inhibiting beta-amyloid production
11/27/2008WO2008070697A3 Stat3 inhibitor having anti-cancer activity and associated methods
11/27/2008WO2008070346A3 Methods for treating pain with reduced nuasea and vomiting
11/27/2008WO2008070268A3 Pharmaceutical compositions
11/27/2008WO2008070086A3 A composition for treatment of connective tissues
11/27/2008WO2008068619A3 Improved method for synthesizing lamotrigine
11/27/2008WO2008066770A3 Ace2 activator compounds and methods of use thereof
11/27/2008WO2008066744A3 Methods and compositions for treating and preventing spinal cord injury and other neuronal disease or injury
11/27/2008WO2008066664A3 Cis-cyclohexyl substituted pyrimidinone derivatives
11/27/2008WO2008064353A3 7,8-saturated-4,5-epoxy-morphinanium analogs
11/27/2008WO2008064043A3 Methods for determining therapeutic efficacy of quinolone analogs
11/27/2008WO2008063756A3 Mucosally non-irritative amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis
11/27/2008WO2008062320A3 Extended release formulations of a proton pump inhibitor
11/27/2008WO2008061671A3 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
11/27/2008WO2008061647A8 Use of a compound as vegf inhibitor
11/27/2008WO2008060622A9 Improved methods and compositions for wound healing
11/27/2008WO2008060381A3 Method for treating pain or opioid dependence using a specific type of non-opioid agent in combination with a selective excitatory-opioid-receptor inactivator
11/27/2008WO2008058210B1 Local administration of gallium compositions to treat pain
1 ... 2974 2975 2976 2977 2978 2979 2980 2981 2982 2983 2984 2985 2986 2987 2988 2989 2990 2991 2992 2993 2994 ... 7860